PIERIS PHARMACEUTICALS, INC. Quarterly Current Income Tax Expense (Benefit) in USD from Q3 2013 to Q3 2014

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Pieris Pharmaceuticals, Inc. annual/quarterly Current Income Tax Expense (Benefit) history and growth rate from Q3 2013 to Q3 2014.
  • Pieris Pharmaceuticals, Inc. Current Income Tax Expense (Benefit) for the quarter ending September 30, 2014 was $0.000.
  • Pieris Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $0.000.
  • Pieris Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2022 was $0.000.
  • Pieris Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
Current Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2014 $0 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-13
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2014-06-02
Q4 2013 $0 Oct 1, 2013 Dec 31, 2013 10-Q 2014-05-14
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.